BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 33452022)

  • 1. A CRISPR/Cas9-Mediated, Homology-Independent Tool Developed for Targeted Genome Integration in Yarrowia lipolytica.
    Cui Z; Zheng H; Zhang J; Jiang Z; Zhu Z; Liu X; Qi Q; Hou J
    Appl Environ Microbiol; 2021 Feb; 87(6):. PubMed ID: 33452022
    [No Abstract]   [Full Text] [Related]  

  • 2. Multiplex gene editing of the Yarrowia lipolytica genome using the CRISPR-Cas9 system.
    Gao S; Tong Y; Wen Z; Zhu L; Ge M; Chen D; Jiang Y; Yang S
    J Ind Microbiol Biotechnol; 2016 Aug; 43(8):1085-93. PubMed ID: 27349768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual CRISPR-Cas9 Cleavage Mediated Gene Excision and Targeted Integration in Yarrowia lipolytica.
    Gao D; Smith S; Spagnuolo M; Rodriguez G; Blenner M
    Biotechnol J; 2018 Sep; 13(9):e1700590. PubMed ID: 29809313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic RNA Polymerase III Promoters Facilitate High-Efficiency CRISPR-Cas9-Mediated Genome Editing in Yarrowia lipolytica.
    Schwartz CM; Hussain MS; Blenner M; Wheeldon I
    ACS Synth Biol; 2016 Apr; 5(4):356-9. PubMed ID: 26714206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiplex Gene Disruption by Targeted Base Editing of Yarrowia lipolytica Genome Using Cytidine Deaminase Combined with the CRISPR/Cas9 System.
    Bae SJ; Park BG; Kim BG; Hahn JS
    Biotechnol J; 2020 Jan; 15(1):e1900238. PubMed ID: 31657874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR-Cas9-Mediated Genome Editing and Transcriptional Control in Yarrowia lipolytica.
    Schwartz C; Wheeldon I
    Methods Mol Biol; 2018; 1772():327-345. PubMed ID: 29754237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPRi repression of nonhomologous end-joining for enhanced genome engineering via homologous recombination in Yarrowia lipolytica.
    Schwartz C; Frogue K; Ramesh A; Misa J; Wheeldon I
    Biotechnol Bioeng; 2017 Dec; 114(12):2896-2906. PubMed ID: 28832943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving CRISPR/Cas9-mediated genome editing efficiency in Yarrowia lipolytica using direct tRNA-sgRNA fusions.
    Abdel-Mawgoud AM; Stephanopoulos G
    Metab Eng; 2020 Nov; 62():106-115. PubMed ID: 32758536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of an efficient CRISPR-iCas9 system in Yarrowia lipolytica for the biosynthesis of carotenoids.
    Chen QH; Qian YD; Niu YJ; Hu CY; Meng YH
    Appl Microbiol Biotechnol; 2023 Oct; 107(20):6299-6313. PubMed ID: 37642716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementing CRISPR-Cas12a for Efficient Genome Editing in Yarrowia lipolytica.
    Yang Z; Xu P
    Methods Mol Biol; 2021; 2307():111-121. PubMed ID: 33847985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EasyCloneYALI: CRISPR/Cas9-Based Synthetic Toolbox for Engineering of the Yeast Yarrowia lipolytica.
    Holkenbrink C; Dam MI; Kildegaard KR; Beder J; Dahlin J; Doménech Belda D; Borodina I
    Biotechnol J; 2018 Sep; 13(9):e1700543. PubMed ID: 29377615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A set of Yarrowia lipolytica CRISPR/Cas9 vectors for exploiting wild-type strain diversity.
    Larroude M; Trabelsi H; Nicaud JM; Rossignol T
    Biotechnol Lett; 2020 May; 42(5):773-785. PubMed ID: 31974649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome Editing in Y. lipolytica Using TALENs.
    Rigouin C; Croux C; Dubois G; Daboussi F; Bordes F
    Methods Mol Biol; 2021; 2307():25-39. PubMed ID: 33847980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment of genomic library technology mediated by non-homologous end joining mechanism in Yarrowia lipolytica.
    Bai Q; Cheng S; Zhang J; Li M; Cao Y; Yuan Y
    Sci China Life Sci; 2021 Dec; 64(12):2114-2128. PubMed ID: 33660223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homology-independent genome integration enables rapid library construction for enzyme expression and pathway optimization in Yarrowia lipolytica.
    Cui Z; Jiang X; Zheng H; Qi Q; Hou J
    Biotechnol Bioeng; 2019 Feb; 116(2):354-363. PubMed ID: 30418662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Standardized Markerless Gene Integration for Pathway Engineering in Yarrowia lipolytica.
    Schwartz C; Shabbir-Hussain M; Frogue K; Blenner M; Wheeldon I
    ACS Synth Biol; 2017 Mar; 6(3):402-409. PubMed ID: 27989123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expansion of YALIcloneHR toolkit for Yarrowia lipolytica combined with Golden Gate and CRISPR technology.
    Shen Q; Yan F; Li YW; Wang J; Ji J; Yan WX; He DC; Song P; Shi TQ
    Biotechnol Lett; 2024 Feb; 46(1):37-46. PubMed ID: 38064043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple Parameters Drive the Efficiency of CRISPR/Cas9-Induced Gene Modifications in Yarrowia lipolytica.
    Borsenberger V; Onésime D; Lestrade D; Rigouin C; Neuvéglise C; Daboussi F; Bordes F
    J Mol Biol; 2018 Oct; 430(21):4293-4306. PubMed ID: 30227135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic engineering of β-carotene biosynthesis in Yarrowia lipolytica.
    Zhang XK; Wang DN; Chen J; Liu ZJ; Wei LJ; Hua Q
    Biotechnol Lett; 2020 Jun; 42(6):945-956. PubMed ID: 32090297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-Strand Annealing Plays a Major Role in Double-Strand DNA Break Repair following CRISPR-Cas9 Cleavage in
    Zhang WW; Matlashewski G
    mSphere; 2019 Aug; 4(4):. PubMed ID: 31434745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.